Cancer Killing Nanoparticles - New Technology

Jan 9 2004

Arming nanoparticles for a seek-and-destroy mission. That’s the goal, outlined in the fall 2003 issue of Odyssey, of Russell J. Mumper, assistant professor of pharmaceutical sciences, and Michael Jay, professor of pharmaceutical sciences, in the University of Kentucky College of Pharmacy, and they are engineering these tiny spheres to target, infiltrate and release cancer-killing drugs into diseased cells.

Mumper, associate director of the UK Center for Pharmaceutical Science and Technology, and Jay, director of the UK Center for Pharmaceutical Science and Technology, formed NanoMed Pharmaceuticals Inc. in 2000 based on their patented technology. They gave two reasons when asked “Why nanoparticles?”: cells can easily take them in (the typical cell is around 8,000 nanometers) and they can circulate in the body for a relatively long time without being removed by macrophages and other cellular police.

Posted 1^st December 2003

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback

Public Comment

Private Feedback to AZoNano.com

Submit

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.